(Q33502832)

27 July 2017

Prevalence and significance of anticardiolipin, anti-beta2 glycoprotein I and anti-prothrombin antibodies in chronic hepatitis C. (English)

1 reference

27 July 2017

1 reference

1 reference

Leroy V

1

1 reference

27 July 2017

Arvieux J

2

1 reference

27 July 2017

Jacob MC

3

1 reference

27 July 2017

Maynard-Muet M

4

1 reference

27 July 2017

Baud M

5

1 reference

27 July 2017

Zarski JP

6

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 June 1998

1 reference

British Journal of Haematology

27 July 2017

1 reference

27 July 2017

101

1 reference

27 July 2017

3

1 reference

27 July 2017

468-474

1 reference

Non-organ specific autoantibodies associated with chronic C virus hepatitis.

27 July 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00722.X

The development of antiphospholipid antibodies in haemophilia is linked to infection with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00722.X

Thrombocytopenia in the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00722.X

Human immunodeficiency virus rather than hepatitis C virus infection is relevant to the development of an anti-cardiolipin antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00722.X

A phospholipid-beta 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00722.X

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00722.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00722.X

Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00722.X

Hepatitis C virus and autoimmunity: Fortuitous association or reality?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00722.X

Immunological disorders in C virus chronic active hepatitis: a prospective case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00722.X

1996 diagnostic and classification criteria for the antiphospholipid/cofactors syndrome: a "mission impossible'?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00722.X

High prevalence of autoimmune phenomena in hepatitis C virus antibody positive patients with lymphoproliferative and connective tissue disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00722.X

Antigenic specificities of antiphospholipid autoantibodies: implications for clinical laboratory testing and diagnosis of the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00722.X

Prevalence of lupus anticoagulant in patients with cirrhosis: relationship with beta-2-glycoprotein I plasma levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00722.X

10.1046/J.1365-2141.1998.00722.X

21 January 2018

Identifiers

DOI

1 reference

27 July 2017

1 reference